ArticleFrontiers in cellular and infection microbiology2025
Antimicrobial and cytotoxic activities of natural (Z)-13-docosenamide derived from
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Mimosa pudica L. extract attenuates endometrial hyperplasia and proliferation of its malignant cell lines: transcript-level insights from a dual in vivo-in vitro model.Molecular biology reports · 2026Article
- Cytotoxic Potential of Marine-Derived Fungi Isolated from Sponges and Brown Algae of Mauritius.Marine drugs · 2026Article
- Chemical Profiling and Scaffold-Based Drug-Discovery Analysis of Bioactive Compounds fromJournal of chemical information and modeling · 2026Article
- Harnessing the seaweed holobiont: antibacterial and antioxidant lead compounds from epiphytic microbiota.International microbiology : the official journal of the Spanish Society for Microbiology · 2026Article
- Multi-analytical and biological insights into Malcolmia grandiflora Kuntze.Scientific reports · 2026Article
- LC-HRMS-Based Metabolomic Profiling and Antioxidant Activity ofAntioxidants (Basel, Switzerland) · 2026Article
- Article
- Metabolic reprogramming of tomato roots during rhizobacteria-mediated defense againstFrontiers in plant science · 2026Article
- GC-MS based bioactive profiling of Phyllanthus niruri and its antibacterial potential through experimental and computational studies.PloS one · 2026Article
- Reimagining invasive weeds through a preliminary antibacterial and phytochemical evaluation of Ipomoea purpurea (L.) Roth floral and seed ethereal extracts.Scientific reports · 2025Article
- Ozone-Assisted Green Upgrading ofFoods (Basel, Switzerland) · 2025Article
- Antimicrobial activity, ergosterol content and phytochemical screening of Rorippa Islandica (Oeder ex Murr.) and Carrichtera annua (L.).Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The synthesis of natural compounds with strong biological activity from affordable sources has proven challenging for scientists. As a natural resource rich in a variety of bioactive substances, fungal metabolites have the potential to be used in medical applications to serve a global purpose towards a sustainable future. Methods: A total of 25 filamentous fungi were isolated, and their secondary metabolites were assessed for their antimicrobial efficiency. Results: The extracellular extract of the strain Conclusion: The remarkable bioactivity of (Z)-13- docosenamide makes it a potential candidate to assist the pipeline for the creation of antibacterial and anticancer drugs, which will help to reduce the incidence of antimicrobial resistance (AMR) and fatalities related to cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.